Your browser doesn't support javascript.
loading
An open randomized multicentre Phase 2 trial to assess the safety of DAV132 and its efficacy to protect gut microbiota diversity in hospitalized patients treated with fluoroquinolones.
Vehreschild, Maria J G T; Ducher, Annie; Louie, Thomas; Cornely, Oliver A; Feger, Celine; Dane, Aaron; Varastet, Marina; Vitry, Fabien; de Gunzburg, Jean; Andremont, Antoine; Mentré, France; Wilcox, Mark H.
Afiliación
  • Vehreschild MJGT; Department of Internal Medicine, Infectious Diseases, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany.
  • Ducher A; Da Volterra, Paris, France.
  • Louie T; Cumming School of Medicine, University of Calgary, Calgary, Canada.
  • Cornely OA; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), University of Cologne, Cologne, Germany.
  • Feger C; Faculty of Medicine and University Hospital Cologne, Chair Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.
  • Dane A; Faculty of Medicine and University Hospital Cologne, Clinical Trials Centre Cologne (ZKS Köln), University of Cologne, Cologne, Germany.
  • Varastet M; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.
  • Vitry F; Da Volterra, Paris, France.
  • de Gunzburg J; EMIBiotech, Paris, France.
  • Andremont A; Danestat, Macclesfield, UK.
  • Mentré F; Da Volterra, Paris, France.
  • Wilcox MH; Da Volterra, Paris, France.
J Antimicrob Chemother ; 77(4): 1155-1165, 2022 03 31.
Article en En | MEDLINE | ID: mdl-35016205

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Clostridioides difficile / Infecciones por Clostridium / Microbioma Gastrointestinal Tipo de estudio: Clinical_trials Límite: Aged / Humans Idioma: En Revista: J Antimicrob Chemother Año: 2022 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Clostridioides difficile / Infecciones por Clostridium / Microbioma Gastrointestinal Tipo de estudio: Clinical_trials Límite: Aged / Humans Idioma: En Revista: J Antimicrob Chemother Año: 2022 Tipo del documento: Article País de afiliación: Alemania